204 related articles for article (PubMed ID: 186874)
1. [Treatment of Kahler's disease].
Foa J; Carcassonne Y
Sem Hop; 1976 Jan; 52(3):165-71. PubMed ID: 186874
[No Abstract] [Full Text] [Related]
2. Remission maintenance therapy for multiple myeloma.
Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of multiple myeloma. Review of the recent trials].
Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
[No Abstract] [Full Text] [Related]
4. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
Bontoux D; Chenbit D; Delbarre F
Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
[No Abstract] [Full Text] [Related]
5. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in chemotherapy of multiple myeloma].
Tortarolo M; Cantore N; Russolillo S; Castaldo C; Buonanno G
Recenti Prog Med; 1978 Jul; 65(1):44-68. PubMed ID: 370935
[No Abstract] [Full Text] [Related]
7. Drug - resistant multiple myeloma. A trial with the M 2 cyclic alkylating agent polychemotherapy.
Buonanno G; Tortarolo M; Valente A; Castaldo C; Russolillo S; Gonnella F
Haematologica; 1978 Feb; 63(1):45-55. PubMed ID: 417971
[No Abstract] [Full Text] [Related]
8. Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.
Lee BJ; Sahakian G; Clarkson BD; Krakoff IH
Cancer; 1974 Feb; 33(2):533-8. PubMed ID: 4812771
[No Abstract] [Full Text] [Related]
9. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
[No Abstract] [Full Text] [Related]
10. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
11. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
[No Abstract] [Full Text] [Related]
12. [Ophthalmoplegia revealing Kahler's disease].
Ardouin M; Urvoy M; Eon JY; Le Blay R
Bull Soc Ophtalmol Fr; 1978 Dec; 78(12):897-9. PubMed ID: 755570
[No Abstract] [Full Text] [Related]
13. [Chemotherapy of malignant skeletal tumors (author's transl)].
Brunner KW; Wagner HP
Ther Umsch; 1979 Jul; 36(7):653-6. PubMed ID: 89708
[No Abstract] [Full Text] [Related]
14. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
Azam L; Delamore IW
Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
[No Abstract] [Full Text] [Related]
15. Results and further perspectives of plasmocytoma chemotherapy.
Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J
Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353
[TBL] [Abstract][Full Text] [Related]
16. Letter: Treatment of myeloma.
Jacobs P; Dubovsky D
Br Med J; 1975 Mar; 1(5958):625. PubMed ID: 1125634
[No Abstract] [Full Text] [Related]
17. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
Case DC; Lee DJ; Clarkson BD
Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
[No Abstract] [Full Text] [Related]
18. Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
van Dijk JM; Sonnenblick M; Weissberg N; Rosin A
Isr J Med Sci; 1986 Feb; 22(2):143-4. PubMed ID: 3753959
[No Abstract] [Full Text] [Related]
19. Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
Strobel ES; Bauchmüller K; Schmitt-Gräff A; Engelhardt M
Ann Hematol; 2005 Nov; 84(12):830-2. PubMed ID: 16132908
[No Abstract] [Full Text] [Related]
20. Alkeran and multiple myeloma.
Med Lett Drugs Ther; 1966 Apr; 8(8):32. PubMed ID: 5913764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
